Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model.
Kim, Eugene
Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model. [electronic resource] - BMC cancer Mar 2016 - 191 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1471-2407
10.1186/s12885-016-2225-1 doi
Angiogenesis Inhibitors--pharmacology
Animals
Antineoplastic Agents--pharmacology
Breast Neoplasms--diagnosis
Cell Line, Tumor
Cell Proliferation--drug effects
Dinoprostone--metabolism
Disease Models, Animal
Endothelial Cells--drug effects
Female
Humans
Magnetic Resonance Imaging
Mice
Neoplasms, Basal Cell--drug therapy
Neovascularization, Pathologic--drug therapy
Phospholipase A2 Inhibitors--pharmacology
Phospholipases A2, Cytosolic--metabolism
Triple Negative Breast Neoplasms--diagnosis
Tumor Burden--drug effects
X-Ray Microtomography
Xenograft Model Antitumor Assays
Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model. [electronic resource] - BMC cancer Mar 2016 - 191 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1471-2407
10.1186/s12885-016-2225-1 doi
Angiogenesis Inhibitors--pharmacology
Animals
Antineoplastic Agents--pharmacology
Breast Neoplasms--diagnosis
Cell Line, Tumor
Cell Proliferation--drug effects
Dinoprostone--metabolism
Disease Models, Animal
Endothelial Cells--drug effects
Female
Humans
Magnetic Resonance Imaging
Mice
Neoplasms, Basal Cell--drug therapy
Neovascularization, Pathologic--drug therapy
Phospholipase A2 Inhibitors--pharmacology
Phospholipases A2, Cytosolic--metabolism
Triple Negative Breast Neoplasms--diagnosis
Tumor Burden--drug effects
X-Ray Microtomography
Xenograft Model Antitumor Assays